Indomethacin and Osteomyelitis chronic - a phase IV clinical study of FDA data

Summary:

Osteomyelitis chronic is reported as a side effect among people who take Indomethacin (indomethacin), especially for people who are male, 60+ old, also take Allopurinol, and have Osteoporosis.

The phase IV clinical study analyzes which people have Osteomyelitis chronic when taking Indomethacin. It is created by eHealthMe based on reports of 16,214 people who have side effects when taking Indomethacin from the FDA, and is updated regularly.

What is Indomethacin?

Indomethacin has active ingredients of indomethacin. It is often used in gout. eHealthMe is studying from 16,884 Indomethacin users. Check the latest studies of Indomethacin.

What is Osteomyelitis chronic?

Osteomyelitis chronic (long lasting infection of bone marrow) is found to be associated with 240 drugs and 223 conditions by eHealthMe. Check the latest studies of Osteomyelitis chronic.

On Aug, 11, 2026

16,214 people reported to have side effects when taking Indomethacin.
Among them, 19 people (0.12%) have Osteomyelitis chronic.

Could Indomethacin cause Osteomyelitis chronic?

Among these 19 people:

What is the gender of people who have Osteomyelitis chronic when taking Indomethacin? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Osteomyelitis chronic when taking Indomethacin? *

What are other drugs people take besides Indomethacin? *

What are other side effects people have besides Osteomyelitis chronic? *

Intervertebral Disc Protrusion (spinal disc protrusion): 15 people, 78.95%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 15 people, 78.95%
Pain: 15 people, 78.95%
Spinal Osteoarthritis (joint cartilage loss in spine): 15 people, 78.95%
Osteonecrosis Of Jaw (death of bone of jaw): 14 people, 73.68%
Death: 13 people, 68.42%
Weakness: 12 people, 63.16%
Anaemia (lack of blood): 10 people, 52.63%
Thrombocytopenia (decrease of platelets in blood): 10 people, 52.63%
Exposed Bone In Jaw: 9 people, 47.37%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 9 people, 47.37%
Prostate Cancer Metastatic: 8 people, 42.11%
Multiple Myeloma (cancer of the plasma cells): 6 people, 31.58%
Metastases To Prostate (cancer spreads to prostate): 1 person, 5.26%
Metastases To Bone (cancer spreads to bone): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Indomethacin and have Osteomyelitis chronic?

- Check whether Osteomyelitis chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indomethacin:

Indomethacin (16,884 reports)

Browse all side effects of Indomethacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis chronic:

Osteomyelitis chronic (240 drugs)

Browse all the conditions that are associated with Osteomyelitis chronic:

Osteomyelitis chronic (223 conditions)

Related publications that referenced our studies

Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C, "Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient", BMC geriatrics, 2012 Nov .
Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C, "Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient", BMC geriatrics, 2012 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on indomethacin (the active ingredients of Indomethacin) and Indomethacin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.